输液市场：按解决方案、按袋类型、按应用、按最终用户、按地区、规模、份额、前景、机会分析，2024-2031

预计到 2024 年，全球输液市场规模将达到 110.4 亿美元，预测期内（2024-2031 年）复合年增长率为 6.1%。

2024 年全球输液市场规模（十亿美元）（按地区）

静脉输液是直接给予病人进入静脉循环的液体。这些输液是无菌、无热原的溶液，包装在单剂量容器中，用于静脉注射，并用于提供水合作用和热量。市面上有不同类型的输液，包括氯化钠、乳酸林格氏液和葡萄糖水溶液。静脉治疗对于营养缺乏和脱水的患者来说是理想的选择。脱水会导致多种影响，包括：

• 体内重要矿物质（电解质）的平衡
• 认知（心理）能力
• 能阶
• 胃肠功能（消化食品并产生尿液和粪便的能力）
• 头痛的频率和强度
• 身体能力
• 皮肤健康

市场动态

腹泻病患病率的增加预计将在预测期内推动全球输液市场的成长。例如，2022年7月，为世界各地儿童提供人道和发展援助的联合国机构UNICEF（联合国国际儿童紧急基金）宣布，2019年，全球整体儿童腹泻占9%。约有484,000 名儿童死亡。

此外，根据 2018 年 9 月发表在《刺胳针传染病》上的一篇论文，腹泻是 2016 年伤残调整生命年 (DALY) 的第三大原因，占全球整体7,440 万 DALY。据同一来源称，腹泻是第八大死因，2016 年全球整体1,655,944 人死亡。

本研究的主要特点

• 本报告以2023年为基准年，对预测期内（2024-2031年）全球输液市场规模进行了详细分析。
• 它揭示了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
• 它根据公司简介、业绩、产品系列、地理分布、分销策略、关键发展和策略等参数，对全球输液市场的主要企业进行了介绍。
• 该报告的见解使公司负责人和高阶经营团队能够就未来产品发布、政府倡议、技术改进、市场扩张和行销策略做出明智的决策。
• 本研究报告针对该产业的各个相关人员，如投资者、产品製造商、经销商、相关人员、研究公司、顾问公司、新参与企业和财务分析师。
• 相关人员可以透过用于分析全球输液市场的各种策略矩阵来促进决策。

目录

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• 一致的机会地图 (COM)

第三章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 市场机会
• 影响分析
• 市场趋势
• 流行病学
• 波特五力分析

第四章全球输液市场 - 冠状病毒（COVID-19）大流行的影响

• 整体影响
• COVID-19 对市场的影响

第五章 全球输液市场，依解决方案，2019-2031

• 介绍
• 生理食盐水
• 生理食盐水（0.9% NaCl）
• 高渗透压盐水
• 聚葡萄糖
• 乳酸林格氏液
• 胺基酸
• 维生素和矿物质
• 肝素和微量元素
• 混合溶液

第六章 全球输液市场，依袋类型，2019-2031

• 介绍
• 大容量袋（250ml以上）
• 小容量袋（250ml以下）

第七章 全球输液市场，依应用分类，2019-2031

• 介绍
• 基础输液
• 营养输液
• 输血
• 药物输注
• 冲洗输液

第 8 章 全球输液市场，依最终用户划分，2019-2031 年

• 介绍
• 医院
• 诊所
• 门诊手术中心
• 居家医疗

第九章全球输液市场，按地区，2019-2031

• 介绍
• 北美洲
• 美国
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 欧洲
• 英国
• 德国
• 义大利
• 法国
• 西班牙
• 俄罗斯
• 欧洲其他地区
• 亚太地区
• 中国
• 印度
• 日本
• 东南亚国协
• 澳洲
• 韩国
• 其他亚太地区
• 中东
• 波湾合作理事会
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中部非洲
• 南非

第10章竞争格局

• 热图分析
• 公司简介
  • Baxter International Inc.
  • ICU Medical, Inc.
  • B. Braun Melsungen Ag
  • Grifols, SA
  • Fresenius Kabi USA, LLC
  • Vifor Pharma Management Ltd.
  • JW Life Science
  • Amanta Healthcare
  • Axa Parenterals Ltd
  • Salius Pharma Private Limited.
  • Pfizer, Inc.
  • Otsuka Pharmaceutical Co., Ltd
  • Ajinomoto Co., Inc.
  • Braun Melsungen AG
  • Soxa Formulations &Research Pvt. Ltd
  • Sichuan Kelun Pharmaceutical Co Ltd

第十一章分析师建议

• 繁荣与衰落
• 综合机会图

第12章 章节

• 参考
• 调查方法

Global intravenous solutions market is estimated to be valued at USD 11.04 Bn in 2024 and is expected to exhibit a CAGR of 6.1% during the forecast period (2024-2031).

Global Intravenous Solutions Market Value (US$ Bn), by Region, 2024

Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation. These fluids are sterile, non-pyrogenic solutions used for fluid replenishment and caloric supply in single dose container for intravenous administration. There are various types of intravenous solutions available in the market such as sodium chloride, lactated ringers, dextrose in water, and others. Intravenous therapy is ideal for patients suffering from nutritional deficiency and dehydration. Dehydration can contribute to various affects such as

• Balance of important minerals (electrolytes) in the body.
• Cognitive (mental) performance.
• Energy level.
• Gastrointestinal function (your ability to digest food and create pee and poop).
• Headache frequency and intensity.
• Physical performance.
• Skin health.

Market Dynamics

Increasing prevalence of diarrhoea is expected to boost the global intravenous solution market growth over the forecast period. For instance, in July 2022, UNICEF (United Nations International Children's Emergency Fund), an agency of the United Nations responsible for providing humanitarian and developmental aid to children worldwide, published a report which accounted for 9 per cent of all deaths among children under age 5 worldwide in 2019 due to Diarrhoea, whereas over 1,300 young children dying each day, or about 484,000 children a year globally due to diarrhoea.

Moreover, according to an article published in the Lancet Infectious Diseases, September 2018, diarrhoea was the third leading cause of disability-adjusted life year (DALYs) in 2016, which accounted for 74.4 million DALYs, globally. According to the same source, diarrhoea was the eighth leading cause of death, which accounted for 1,655,944 deaths in 2016 globally.

Key features of the study:

• This report provides an in-depth analysis of the global intravenous solutions market, market size (US$ Bn), and compound annual growth rate (CAGR (%)) for the forecast period: 2024 - 2031, considering 2023 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global intravenous solutions market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include, Baxter International Inc. ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited, Pfizer, Inc, Otsuka Pharmaceutical Co., Ltd, Ajinomoto Co., Inc., B. Braun Melsungen AG, Soxa Formulations & Research Pvt.Ltd, Sichuan Kelun Pharmaceutical Co Ltd.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global intravenous solutions market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global intravenous solutions market.

Detailed Segmentation:

• Global Intravenous Solutions Market, By Solution type:
  • Saline
  • Normal Saline (0.9% NaCl)
  • Hypertonic Saline
  • Dextran
  • Lactated Ringer's
  • Amino Acid
  • Vitamins & Minerals
  • Heparin and Trace Elements
  • Mixed Solutions
• Global Intravenous Solutions Market, By Bag type:
  • Large Volume Bags (greater than 250ml)
  • Small Volume Bags (less than 250ml)
• Global Intravenous Solutions Market, By Application:
  • Basic IV Solution
  • Nutritional IV Solution
  • Blood IV Solution
  • Drug IV Solution
  • Irrigation IV Solution
• Global Intravenous Solutions Market, By End User:
  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers
  • Home Care Settings
• Global Intravenous Solutions Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Baxter International Inc.
  • ICU Medical, Inc.
  • Braun Melsungen Ag
  • Grifols, S.A.
  • Fresenius Kabi USA, LLC
  • Vifor Pharma Management Ltd.
  • JW Life Science
  • Amanta Healthcare
  • Axa Parenterals Ltd.
  • Salius Pharma Private Limited.
  • Pfizer, Inc.
  • Otsuka Pharmaceutical Co., Ltd
  • Ajinomoto Co., Inc.
  • Braun Melsungen AG
  • Soxa Formulations & Research Pvt.Ltd
  • Sichuan Kelun Pharmaceutical Co Ltd

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Solution
  • Market Snapshot, By Bag Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Epidemiology
• Porter's Five Forces Analysis

4. Global Intravenous Solutions Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• COVID-19 Impact on the market

5. Global Intravenous Solutions Market, By Solution, 2019 - 2031, (US$ Billion)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Saline
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
• Normal Saline (0.9% NaCl)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
• Hypertonic Saline
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
• Dextran
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
• Lactated Ringer's
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
• Amino Acid
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
• Vitamins & Minerals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
• Heparin and trace elements
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
• Mixed Solutions
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

6. Global Intravenous Solutions Market, By Bag Type, 2019 - 2031, (US$ Billion)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020- 2031
  • Segment Trends
• Large Volume Bags (greater than 250ml)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
• Small Volume Bags (less than 250ml)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

7. Global Intravenous Solutions Market, By Application, 2019 - 2031, (US$ Billion)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020- 2031
  • Segment Trends
• Basic IV Solution
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
• Nutritional IV Solution
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
• Blood IV Solution
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
• Drug IV Solution
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
• Irrigation IV Solution
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

8. Global Intravenous Solutions Market, By End User, 2019 - 2031, (US$ Billion)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospital
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
• Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
• Ambulatory Surgery Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
• Home care Settings
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

9. Global Intravenous Solutions Market, By Region, 2019 - 2031, (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Regions, 2020-2031
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
• GCC
• Israel
• Rest of Middle East
• Africa
• North Africa
• Central Africa
• South Africa

10. Competitive Landscape

• Heat Map Analysis
• Company Profile
  • Baxter International Inc.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • ICU Medical, Inc.
  • B. Braun Melsungen Ag
  • Grifols, S.A
  • Fresenius Kabi USA, LLC
  • Vifor Pharma Management Ltd.
  • JW Life Science
  • Amanta Healthcare
  • Axa Parenterals Ltd
  • Salius Pharma Private Limited.
  • Pfizer, Inc.
  • Otsuka Pharmaceutical Co., Ltd
  • Ajinomoto Co., Inc.
  • Braun Melsungen AG
  • Soxa Formulations & Research Pvt. Ltd
  • Sichuan Kelun Pharmaceutical Co Ltd

11. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. Section

• References
• Research Methodology
• About Us and Sales Contact